Flagship Pioneering

Flagship Pioneering announces Michael Nally, CEO of #FlagshipFounded Generate:Biomedicines and Flagship CEO-Partner, as the recipient of this year’s Bigger Leaps Award.    At Generate, Mike has paired scientific vision with operational discipline, and — just as importantly — has built a culture that turns aspiration into achievement, uniting more than 300 “Generators” around a shared mission to engineer the future of medicine. For more: https://bit.ly/3Ki9qHn

Meet Aranzazu Ballesteros — a pioneering Innovation Enabler who turns process into possibility, building systems that empower Flagship’s people to focus on the science and creativity that fuel innovation. https://bit.ly/4p2MZFl Our Why I Pioneer campaign celebrates not just the breakthroughs we’ve achieved, but the people who make them happen. Read more about the passion and purpose that drive Aranza and other members of the team at Flagship, shaping our culture of fearless exploration and discovery: http://bit.ly/4fH6LlE #WeAreFlagship #BiggerLeaps

It has been a globetrotting week at Flagship Pioneering as we announced three major new international partnerships: - A collaboration with The Francis Crick Institute in the UK to jointly explore areas of scientific opportunity - A pact between Apriori Bio and A*STAR - Agency for Science, Technology and Research - in Singapore to co-develop next-generation flu vaccines - A partnership for clinical research with King Abdullah International Medical Research Center (كيمارك KAIMRC) in Saudi Arabia Through these agreements, we will bring our groundbreaking science and unique innovation model to more people than ever before. We will help advance U.S. biotech as the gold standard both at home and abroad. And we will significantly broaden the positive impact our work can have on human and planetary health. 

In a recent conversation with SEMAFOR, our Founder & CEO Noubar Afeyan describes how Flagship converts breakthrough innovations into companies that deliver impact for people and the planet through the process of “entrepreneuring.” On entrepreneuring, he says: "We changed the end of the word to indicate that you’re doing something, not being someone.” Read more about Noubar’s perspective on AI, innovation, and the conditions that enable discovery to thrive: https://bit.ly/3Kf8qDS

The biological complexity of Parkinson’s Disease demands a new approach to find more impactful targets and medicines. This partnership unites #FlagshipFounded Valo Health’s platform with Merck KGaA, Darmstadt, Germany’s prowess in neurology R&D, and promises #BiggerLeaps for patients.

We are advancing our collaboration with GSK through new agreements with #FlagshipFounded ProFound Therapeutics and Quotient Therapeutics. Together we will discover and validate novel targets and therapies for respiratory and liver diseases — turning pioneering science into lasting impact for patients. Read more: https://bit.ly/4plw6FB #BiggerLeaps

Check out the latest advancement in our partnership with A*STAR - Agency for Science, Technology and Research to spur innovation in human health in Singapore, and how Apriori Bio is working to develop stronger protections against influenza.

Today, Flagship and the King Abdullah International Medical Research Center (كيمارك KAIMRC) announced a strategic partnership to advance transformative new medicines globally. The partnership marks the latest step by Flagship and its companies to drive breakthrough innovations for the benefit of patients on a global scale. Learn more here: https://bit.ly/486Xu35

At Flagship, we are committed to driving impact globally for patients and the planet. As we bridge our ecosystem with biotech ecosystems around the world — including in the UK — we see firsthand how AI and global competition are pushing these ecosystems to evolve. The UK has a strong scientific base and a regulatory environment that fosters innovation. To ensure these strengths carry the UK into the next era, we’ve collaborated with the Tony Blair Institute for Global Change to outline four key areas that can help the UK lead. This paper draws on insights from experts across Flagship, TBI, and the broader UK biotech sector, and shares a path that positions the UK as a leader in this new chapter in biotech. Read more here: https://lnkd.in/dq-5H2Ug

🧬 The Francis Crick Institute x Flagship Pioneering 🚀 As we celebrate #UKLifeSciencesWeek, I’m proud to share that Flagship Pioneering and The Francis Crick Institute – Europe’s largest biomedical research institute – have today announced a new collaboration to advance life sciences innovation and accelerate the translation of cutting-edge science into real-world impact across the UK and beyond. By uniting the Crick’s extraordinary depth of scientific insight and research excellence with Flagship’s proven model for creating and scaling platform-based biotechnology companies, we will jointly explore bold new scientific opportunities and build transformative platforms and therapeutic pipelines that can deliver meaningful breakthroughs for patients worldwide. This partnership is a heartfelt celebration of the exceptional talent and institutions that make the UK one of the greatest places on earth to do discovery science. Feeling incredibly privileged to play even a small part in connecting world-class curiosity-driven research with a proven path to impact. The future of medicine will be written through collaborations built on trust, shared ambition, and an unrelenting focus on human health. Grateful to everyone at the Crick and Flagship who made this possible – the best is yet to come 🚀 🔗 Full announcement: https://lnkd.in/e-W-2yf2 “The advance of science and the advance of society are intertwined — each depends on our willingness to explore together.” — Francis Crick Sutha Satkunarajah | Sophie Ghazal | Lena Afeyan, PhD MBA | Emma French | Justine Levin-Allerhand | Noubar Afeyan | Alec Reynolds | Rupert Vessey | JB de Labarthe | Kate Wilson | Simon Brunner | Alex Goldsmith | Olivia Offner | Mark Stevenson | Stephen Mayhew | Paul Mercer | Henry Robinson